DEBORAH HILDRETH: Open Payments
NPI 1821109992 · AVERILL PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$826 in 47 payments from 14 companies in 2025. Trend: 2023 $1,256 · 2024 $1,217 · 2025 $826
Food & beverage: $826
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $194 |
| GlaxoSmithKline, LLC. | 5 | $106 |
| Novo Nordisk Inc | 4 | $88 |
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| Merck Sharp & Dohme LLC | 4 | $64 |
| PFIZER INC. | 3 | $57 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $57 |
| Axsome Therapeutics, Inc. | 2 | $45 |
| Lilly USA, LLC | 2 | $33 |
| Renalytix AI, Inc. | 2 | $30 |
Products named: UBRELVY, TRELEGY ELLIPTA, AIRSUPRA, ELIQUIS, Kerendia, Wegovy, Auvelity, CREON.
Industry payments across NY — which companies pay providers there.
